Published in Surgery on January 01, 2002
Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol (2005) 0.98
Intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am (2014) 0.95
Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series. World J Gastroenterol (2013) 0.91
HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice. World J Gastroenterol (2004) 0.90
Staging of peripheral-type intrahepatic cholangiocarcinoma: appraisal of the new TNM classification and its modifications. World J Surg (2011) 0.88
Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol (2008) 0.87
MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line. PLoS One (2013) 0.87
Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma. World J Surg (2005) 0.87
Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today (2011) 0.86
Initial experiences with laparoscopy-assisted and total laparoscopy for anatomical liver resection: a preliminary study. J Korean Med Sci (2006) 0.81
Characterization of a novel rat cholangiocarcinoma cell culture model-CGCCA. World J Gastroenterol (2011) 0.80
Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma. Onco Targets Ther (2015) 0.79
Synchronous double primary cancer - intrahepatic cholangiocarcinoma with bone metastases and thyroid carcinoma: A case report. Oncol Lett (2015) 0.79
Malignant obstructive jaundice - brachytherapy as a tool for palliation. J Contemp Brachytherapy (2013) 0.78
Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein. World J Gastroenterol (2008) 0.77
Pancreatic recurrence of intrahepatic cholangiocarcinoma: Case report and review of the literature. World J Gastrointest Surg (2014) 0.75
Diagnosis and surgical treatment of intrahepatic hepatolithiasis combined with cholangiocarcinoma. World J Surg (2014) 0.75
Primarily screening and analyzing ESTs differentially expressed in rats' primary liver cancer. Chin J Cancer Res (2013) 0.75
Advantages of totally laparoscopic distal gastrectomy over laparoscopically assisted distal gastrectomy for gastric cancer. Surg Endosc (2009) 2.41
Obstructing spontaneous major shunt vessels is mandatory to keep adequate portal inflow in living-donor liver transplantation. Transplantation (2013) 2.14
Long-term favorable surgical results of laparoscopic hepatic resection for hepatocellular carcinoma in patients with cirrhosis: a single-center experience over a 10-year period. J Am Coll Surg (2014) 2.06
Indocyanine Green Fluorescent Imaging for Hepatic Resection of the Right Hepatic Vein Drainage Area. J Am Coll Surg (2015) 2.05
FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma. Hepatology (2013) 1.81
Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncol Rep (2012) 1.81
Transcriptional repressor snail and progression of human hepatocellular carcinoma. Clin Cancer Res (2003) 1.79
Rab13 mediates the continuous endocytic recycling of occludin to the cell surface. J Biol Chem (2004) 1.78
Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation (2009) 1.69
A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg (2014) 1.65
Risk factors for and management of delayed intraperitoneal hemorrhage after pancreatic and biliary surgery. Am J Surg (2007) 1.64
Strategies for improving the outcomes of small-for-size grafts in adult-to-adult living-donor liver transplantation. J Hepatobiliary Pancreat Surg (2008) 1.64
Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol (2002) 1.58
Reconstruction of the middle hepatic vein tributaries using the recipient's recanalized umbilical vein in right-lobe living-donor liver transplantation. Surgery (2006) 1.58
Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin Cancer Res (2004) 1.58
Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg (2013) 1.56
Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation. Transplantation (2008) 1.51
Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey. Transpl Int (2014) 1.49
A new technique to acquire additional liver volume for left lobe graft in living donor liver transplantation. Hepatogastroenterology (2008) 1.42
The changes of the medial right lobe, transplanted with left lobe liver graft from living donors. Transplantation (2009) 1.42
Is an elderly recipient a risk for living donor adult liver transplantation? Hepatogastroenterology (2008) 1.38
Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients. J Am Coll Surg (2007) 1.37
Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation. Pancreas (2008) 1.33
Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma. Oncology (2007) 1.33
Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res (2013) 1.29
Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. Hepatogastroenterology (2003) 1.29
Japanese clinical practice guidelines for pancreaticobiliary maljunction. J Gastroenterol (2012) 1.18
Overexpression of a novel superoxide-producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon. Cancer Lett (2005) 1.18
Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis. J Natl Cancer Inst (2006) 1.16
Rapid-growing solitary necrotic nodule of the liver. J Med Invest (2006) 1.15
The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen. Int J Clin Oncol (2011) 1.13
Comparison of long-term prognosis of laparoscopy-assisted gastrectomy and conventional open gastrectomy with special reference to D2 lymph node dissection. Surg Endosc (2012) 1.12
Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells. Int J Cancer (2003) 1.12
Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology (2005) 1.12
The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft. Transpl Int (2008) 1.12
Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res (2010) 1.11
Donor risk in adult-to-adult living donor liver transplantation: impact of left lobe graft. Transplantation (2009) 1.10
Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma. J Gastroenterol (2009) 1.10
Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation (2007) 1.10
Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol (2010) 1.09
Establishment of regional alliance clinical pathways for gastrointestinal cancer in Tokushima. Fukuoka Igaku Zasshi (2011) 1.09
Risk model for right hemicolectomy based on 19,070 Japanese patients in the National Clinical Database. J Gastroenterol (2013) 1.09
Sarcopenia is a prognostic factor in living donor liver transplantation. Liver Transpl (2014) 1.07
Total gastrectomy risk model: data from 20,011 Japanese patients in a nationwide internet-based database. Ann Surg (2014) 1.07
Accurate preoperative estimation of liver-graft volumetry using three-dimensional computed tomography. Transplantation (2003) 1.05
Clinical roles of increased populations of Foxp3+CD4+ T cells in peripheral blood from advanced pancreatic cancer patients. Pancreas (2006) 1.05
New technique for the retraction of the liver in laparoscopic gastrectomy. Surg Endosc (2008) 1.04
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double‑blind, placebo‑controlled trial of goshajinkigan to prevent oxaliplatin‑induced neuropathy. Cancer Chemother Pharmacol (2013) 1.03
Biliary strictures in living donor liver transplantation: incidence, management, and technical evolution. Liver Transpl (2006) 1.03
Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma. Hepatology (2003) 1.03
Cryopreservation of isolated primary rat hepatocytes: enhanced survival and long-term hepatospecific function. Ann Surg (2005) 1.03
Sonic hedgehog relates to colorectal carcinogenesis. J Gastroenterol (2009) 1.02
Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. Proc Natl Acad Sci U S A (2008) 1.02
Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg (2007) 1.02
Current concept of small-for-size grafts in living donor liver transplantation. Surg Today (2008) 1.02
A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. Surgery (2002) 1.01
Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma. Cancer Detect Prev (2004) 1.01
The effects of the Kampo medicine (Japanese herbal medicine) "Daikenchuto" on the surgical inflammatory response following laparoscopic colorectal resection. Surg Today (2011) 1.01
Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma. Hepatology (2002) 1.01
Evaluation of reconstruction after proximal gastrectomy: prospective comparative study of jejunal interposition and jejunal pouch interposition. Hepatogastroenterology (2006) 1.00
The role of MTA1 gene expression in human hepatocellular carcinoma. Oncol Rep (2003) 1.00
Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: a placebo-controlled double-blind randomized phase II study (the GONE Study). Jpn J Clin Oncol (2009) 0.99
Outcome analysis in adult-to-adult living donor liver transplantation using the left lobe. Liver Transpl (2003) 0.99
Significance of sonic hedgehog signaling after massive hepatectomy in a rat. Surg Today (2012) 0.98
Human adipose-derived stem cells: potential clinical applications in surgery. Surg Today (2010) 0.98
Galectin-3 expression is a potent prognostic marker in colorectal cancer. Anticancer Res (2005) 0.98
Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2011) 0.98
Kampo medicine "Dai-kenchu-to" prevents bacterial translocation in rats. Dig Dis Sci (2008) 0.98
Laparoscopic splenectomy may be a superior supportive intervention for cirrhotic patients with hypersplenism. J Gastroenterol Hepatol (2009) 0.97
New Pathologic Stratification of Microvascular Invasion in Hepatocellular Carcinoma: Predicting Prognosis After Living-donor Liver Transplantation. Transplantation (2015) 0.97
Risk Model for Distal Gastrectomy When Treating Gastric Cancer on the Basis of Data From 33,917 Japanese Patients Collected Using a Nationwide Web-based Data Entry System. Ann Surg (2015) 0.97
Effect of intraportal infusion to improve small for size graft injury in living donor adult liver transplantation. Transpl Int (2005) 0.97
Graft-versus-host disease following living donor liver transplantation. Liver Transpl (2004) 0.96
Surgical outcome of patients with hepatocellular carcinoma originating in the caudate lobe. Am J Surg (2005) 0.96
Irinotecan injures tight junction and causes bacterial translocation in rat. J Surg Res (2010) 0.96
Laparoscopic removal of a foreign body in the pelvic cavity through one port using a flexible cholangioscope. Dig Surg (2009) 0.95
Clinicopathologic risk factors for recurrence after a curative hepatic resection for hepatocellular carcinoma. Surgery (2002) 0.95
Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy. Ann Surg Oncol (2014) 0.95
Real time elastography for noninvasive diagnosis of liver fibrosis. J Hepatobiliary Pancreat Surg (2009) 0.95
Mucin-hypersecreting bile duct neoplasm characterized by clinicopathological resemblance to intraductal papillary mucinous neoplasm (IPMN) of the pancreas. World J Surg Oncol (2007) 0.94
A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients. Ann Surg (2015) 0.94
Liver metastasis with intraductal invasion originating from rectal cancer: report of a case. Surg Today (2008) 0.94